Regarding factor V Leiden, prothrombin G20210A, and MTHFR mutation, there is significant statistical increase in the percentage of factor V Leiden and MTHFR mutation in ET patients compared to the control group (Table 1). This evidence concerns the gene MTHFR and essential thrombocythemia.